DEZAFTAN MED

This brand name is authorized in Poland.

Active ingredients

The drug DEZAFTAN MED contains a combination of these active pharmaceutical ingredients (APIs):

1	Cetylpyridinium UNII D9OM4SK49P - CETYLPYRIDINIUM CHLORIDE
	Cetylpyridinium is an antiseptic with activity against both gram positive and gram negative organisms.
	Read more about Cetylpyridinium
2	Lidocaine UNII V13007Z41A - LIDOCAINE HYDROCHLORIDE
	Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.
	Read more about Lidocaine
3	Zinc gluconate UNII U6WSN5SQ1Z - ZINC GLUCONATE
	Read more about Zinc gluconate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A01AD11	Various	A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AD Other agents for local oral treatment
Discover more medicines within A01AD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
PL	Rejestru Produktów Leczniczych	100381482, 100385505